Together with these studies showing that galectin-3 could be an indicator of vascular dysfunction and be associated with the inflammatory response of several diseases, our study showed that galectin-3 and CRP were independently associated with VRI and that galectin-3 might modulate endothelial dysfunction through the regulation of inflammatory pathways in patients with CKD. The gene discussed is CRP; the disease is endothelial dysfunction.